JPS6348270B2 - - Google Patents
Info
- Publication number
- JPS6348270B2 JPS6348270B2 JP55164174A JP16417480A JPS6348270B2 JP S6348270 B2 JPS6348270 B2 JP S6348270B2 JP 55164174 A JP55164174 A JP 55164174A JP 16417480 A JP16417480 A JP 16417480A JP S6348270 B2 JPS6348270 B2 JP S6348270B2
- Authority
- JP
- Japan
- Prior art keywords
- furanone
- compound
- reaction
- methyl
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 α-naphthyl Chemical group 0.000 description 54
- 150000001875 compounds Chemical class 0.000 description 45
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 30
- 238000006243 chemical reaction Methods 0.000 description 26
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- 239000002904 solvent Substances 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 125000000217 alkyl group Chemical group 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 238000003756 stirring Methods 0.000 description 8
- 239000002585 base Substances 0.000 description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- GAEKPEKOJKCEMS-UHFFFAOYSA-N gamma-valerolactone Chemical compound CC1CCC(=O)O1 GAEKPEKOJKCEMS-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- DUYAAUVXQSMXQP-UHFFFAOYSA-N ethanethioic S-acid Chemical class CC(S)=O DUYAAUVXQSMXQP-UHFFFAOYSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 3
- 150000004967 organic peroxy acids Chemical class 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- IKCLCGXPQILATA-UHFFFAOYSA-N 2-chlorobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1Cl IKCLCGXPQILATA-UHFFFAOYSA-N 0.000 description 2
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229960004676 antithrombotic agent Drugs 0.000 description 2
- 239000000010 aprotic solvent Substances 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- VIHAEDVKXSOUAT-UHFFFAOYSA-N but-2-en-4-olide Chemical class O=C1OCC=C1 VIHAEDVKXSOUAT-UHFFFAOYSA-N 0.000 description 2
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- JWUKZUIGOJBEPC-UHFFFAOYSA-N phenyl thiohypochlorite Chemical compound ClSC1=CC=CC=C1 JWUKZUIGOJBEPC-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- PAIRPKMSBFJAQB-UHFFFAOYSA-N 1-methyl-4-phenylsulfanylsulfonylbenzene Chemical compound C1=CC(C)=CC=C1S(=O)(=O)SC1=CC=CC=C1 PAIRPKMSBFJAQB-UHFFFAOYSA-N 0.000 description 1
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- 125000000579 2,2-diphenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000001617 2,3-dimethoxy phenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 1
- KLIDCXVFHGNTTM-UHFFFAOYSA-N 2,6-dimethoxyphenol Chemical group COC1=CC=CC(OC)=C1O KLIDCXVFHGNTTM-UHFFFAOYSA-N 0.000 description 1
- QYYCPWLLBSSFBW-UHFFFAOYSA-N 2-(naphthalen-1-yloxymethyl)oxirane Chemical compound C=1C=CC2=CC=CC=C2C=1OCC1CO1 QYYCPWLLBSSFBW-UHFFFAOYSA-N 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- 125000006179 2-methyl benzyl group Chemical group [H]C1=C([H])C(=C(C([H])=C1[H])C([H])([H])*)C([H])([H])[H] 0.000 description 1
- IXOFPUCWZCAFJX-UHFFFAOYSA-N 2-phenylethanethioic s-acid Chemical compound SC(=O)CC1=CC=CC=C1 IXOFPUCWZCAFJX-UHFFFAOYSA-N 0.000 description 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical compound NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000872931 Myoporum sandwicense Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- ATKJLMWDXASAJA-UHFFFAOYSA-N benzenesulfonylsulfanylbenzene Chemical compound C=1C=CC=CC=1S(=O)(=O)SC1=CC=CC=C1 ATKJLMWDXASAJA-UHFFFAOYSA-N 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical compound O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- GCFHZZWXZLABBL-UHFFFAOYSA-N ethanol;hexane Chemical compound CCO.CCCCCC GCFHZZWXZLABBL-UHFFFAOYSA-N 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000004030 farnesyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002350 geranyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 125000005935 hexyloxycarbonyl group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical compound [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 description 1
- SIAPCJWMELPYOE-UHFFFAOYSA-N lithium hydride Chemical compound [LiH] SIAPCJWMELPYOE-UHFFFAOYSA-N 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- OVEHNNQXLPJPPL-UHFFFAOYSA-N lithium;n-propan-2-ylpropan-2-amine Chemical compound [Li].CC(C)NC(C)C OVEHNNQXLPJPPL-UHFFFAOYSA-N 0.000 description 1
- PDZGAEAUKGKKDE-UHFFFAOYSA-N lithium;naphthalene Chemical compound [Li].C1=CC=CC2=CC=CC=C21 PDZGAEAUKGKKDE-UHFFFAOYSA-N 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Furan Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は新規な2(5H)―フラノン誘導体に関
する。
本発明の2(5H)―フラノン誘導体は文献未載
の新規化合物であつて、下記一般式(1)で表わされ
る。
〔式中、R1は低級アルキル基、ナフチル基、
モノ―またはジ―フエニル低級アルキル基(該フ
エニル環は低級アルキル基で置換されていてもよ
い)、フエニル基(環上にハロゲン原子、低級ア
ルキル基、ハロゲン置換低級アルキル基、低級ア
ルコキシ基から選ばれた1個または2個の置換基
を有していてもよい)、または式
The present invention relates to novel 2(5H)-furanone derivatives. The 2(5H)-furanone derivative of the present invention is a novel compound that has not been described in any literature, and is represented by the following general formula (1). [In the formula, R 1 is a lower alkyl group, a naphthyl group,
A mono- or diphenyl lower alkyl group (the phenyl ring may be substituted with a lower alkyl group), a phenyl group (a halogen atom on the ring, a lower alkyl group, a halogen-substituted lower alkyl group, a lower alkoxy group) may have one or two substituents), or the formula
【式】(m=1〜3の整
数)で示される基、R2は水素原子または低級ア
ルコキシカルボニル基を示す。ただし、R2が水
素原子でR1がベンジル基の場合を除く〕
上記一般式(1)において、R1,R2で示される各
基は具体的には次のものが挙げられる。
すなわち、低級アルキル基としては、メチル、
エチル、プロピル、ブチル、tert―ブチル基な
ど、ナフチル基としては、α―ナフチル、β―ナ
フチル基など、フエニル環が低級アルキル基で置
換されていてもよいモノ―またはジ―フエニル低
級アルキル基としては、2―メチルベンジル、4
―メチルベンジル、α―フエネチル、β―フエネ
チル、2―フエニルプロピル、3―フエニルプロ
ピル、4―フエニルブチル、ジフエニルメチル、
2,2―ジフエニルエチル、1―(2―メチルフ
エニル)エチル、2―(4―メチルフエニル)エ
チル、1―(4―メチルフエニル)―2―フエニ
ルエチル、2―(2―メチルフエニル)―2―フ
エニルエチル、1―(4―メチルフエニル)―2
―フエニルプロピル基などが挙げられる。
ハロゲン原子、低級アルキル基、ハロゲン置換
低級アルキル基、低級アルコキシ基から選ばれた
1個または2個の置換基を有していてもよいフエ
ニル基としては、フエニル、4―クロルフエニ
ル、2―クロルフエニル、3―クロルフエニル、
4―フルオロフエニル、2―フルオロフエニル、、
2―ブロムフエニル、3―フルオロフエニル、4
―メトキシフエニル、2―メトキシフエニル、3
―メトキシフエニル、3―エトキシフエニル、4
―ブトキシフエニル、4メチルフエニル、3―メ
チルフエニル、2―メチルフエニル、2―エチル
フエニル、4―ブチルフエニル、3―トリフルオ
ロメチルフエニル、4―トリフルオロメチルフエ
ニル、2,6―ジクロルフエニル、2,4―ジク
ロルフエニル、2,3―ジメトキシフエニル、
2,6―ジメトキシフエニル、3,4―ジメトキ
シフエニル、3,5―ジメトキシフエニル、2,
3―ジメチルフエニル、2,4―ジメチルフエニ
ル、2,5―ジメチルフエニル、2,6―ジメチ
ルフエニル、3,4―ジメチルフエニル、3,5
―ジメチルフエニル、4―クロル―5―メチルフ
エニル、2―ブロム―4―メチルフエニル、2―
クロル―5―メチルフエニル、4―クロル―2―
メチルフエニル、―4−クロル―3―メチルフエ
ニル、3―メトキシ―2―メチルフエニル基など
が挙げられる。
式In the group represented by the formula (m=an integer of 1 to 3), R 2 represents a hydrogen atom or a lower alkoxycarbonyl group. However, this excludes the case where R 2 is a hydrogen atom and R 1 is a benzyl group.] In the above general formula (1), the groups represented by R 1 and R 2 include the following. That is, lower alkyl groups include methyl,
Examples of naphthyl groups such as ethyl, propyl, butyl, and tert-butyl groups include mono- or di-phenyl lower alkyl groups in which the phenyl ring may be substituted with a lower alkyl group such as α-naphthyl and β-naphthyl groups. is 2-methylbenzyl, 4
-Methylbenzyl, α-phenethyl, β-phenethyl, 2-phenylpropyl, 3-phenylpropyl, 4-phenylbutyl, diphenylmethyl,
2,2-diphenylethyl, 1-(2-methylphenyl)ethyl, 2-(4-methylphenyl)ethyl, 1-(4-methylphenyl)-2-phenylethyl, 2-(2-methylphenyl)-2-phenylethyl, 1- (4-methylphenyl)-2
- phenylpropyl group, etc. Examples of the phenyl group which may have one or two substituents selected from a halogen atom, a lower alkyl group, a halogen-substituted lower alkyl group, and a lower alkoxy group include phenyl, 4-chlorophenyl, 2-chlorophenyl, 3-chlorphenyl,
4-fluorophenyl, 2-fluorophenyl,
2-bromphenyl, 3-fluorophenyl, 4
-methoxyphenyl, 2-methoxyphenyl, 3
-methoxyphenyl, 3-ethoxyphenyl, 4
-butoxyphenyl, 4-methylphenyl, 3-methylphenyl, 2-methylphenyl, 2-ethylphenyl, 4-butylphenyl, 3-trifluoromethylphenyl, 4-trifluoromethylphenyl, 2,6-dichlorophenyl, 2,4-dichlorophenyl, 2,3-dimethoxyphenyl,
2,6-dimethoxyphenyl, 3,4-dimethoxyphenyl, 3,5-dimethoxyphenyl, 2,
3-dimethylphenyl, 2,4-dimethylphenyl, 2,5-dimethylphenyl, 2,6-dimethylphenyl, 3,4-dimethylphenyl, 3,5
-dimethylphenyl, 4-chloro-5-methylphenyl, 2-bromo-4-methylphenyl, 2-
Chlor-5-methylphenyl, 4-chloro-2-
Examples include methylphenyl, -4-chloro-3-methylphenyl, and 3-methoxy-2-methylphenyl groups. formula
【式】で示される基と
しては、プレニル、ゲラニル、ネリル、フアルネ
シル基など、低級アルコキシカルボニル基として
は、メトキシカルボニル、エトキシカルボニル、
プロポキシカルボニル、イソプロポキシカルボニ
ル、ブトキシカルボニル、tert―ブトキシカルボ
ニル、ペンチルオキシカルボニル、ヘキシルオキ
シカルボニル基などが挙げられる。
本発明の代表的な化合物を以下に列挙する。
5―フエノキシメチル―2(5H)―フラノン
5―(4―クロルフエノキシ)メチル―2
(5H)―フラノン
5―(4―メチルフエノキシ)メチル―2
(5H)―フラノン
5―(4―メトキシフエノキシ)メチル―2
(5H)―フラノン
5―(3―トリフルオロメチルフエノキシ)メ
チル―2(5H)―フラノン
5―(2,6―ジメチルフエノキシ)メチル―
2(5H)―フラノン
5―(3―クロル―4―メチルフエノキシ)メ
チル―2(5H)―フラノン
5―(β―ナフトキシ)メチル―2(5H)―フ
ラノン
5―(α―ナフトキシ)メチル―2(5H)―フ
ラノン
5―(3―メトキシ―2―メチルフエノキシ)
メチル―2(5H)―フラノン
5―(2―ブロムフエノキシ)メチル―2
(5H)―フラノン
5―(3―フルオロフエノキシ)メチル―2
(5H)―フラノン
5―(2,3―ジメチルフエノキシ)メチル―
2(5H)―フラノン
5―(4―クロル―5―メチルフエノキシ)メ
チル―2(5H)―フラノン
5―(α―フエネチルオキシ)メチル―2
(5H)―フラノン
5―(β―フエネチルオキシ)メチル―2
(5H)―フラノン
5―(4―フエニルブトキシ)メチル―2
(5H)―フラノン
5―ジフエニルメトキシメチル―2(5H)―フ
ラノン
5―(2,2―ジフエニルエトキシ)メチル―
2(5H)―フラノン
5―プレニルオキシメチル―2(5H)―フラノ
ン
5―ゲラニルオキシメチル―2(5H)―フラノ
ン
5―フアルネシルオキシメチル―2(5H)―フ
ラノン
5―メトキシメチル―2(5H)―フラノン
5―n―ブトキシメチル―2(5H)―フラノン
5―イソプロポキシメチル―2(5H)―フラノ
ン
3―エトキシカルボニル―5―フエノキシメチ
ル―2(5H)―フラノン
3―エトキシカルボニル―5―(4―クロルフ
エノキシ)メチル―2(5H)―フラノン
3―エトキシカルボニル―5―(2,2―ジフ
エニルエトキシ)メチル―2(5H)―フラノン
3―エトキシカルボニル―5―ジフエニルメト
キシメチル―2(5H)―フラノン
3―エトキシカルボニル―5―(β―ナフトキ
シ)メチル―2(5H)―フラノン
3―エトキシカルボニル―5―(α―ナフトキ
シ)メチル―2(5H)―フラノン
3―エトキシカルボニル―5―ゲラニルオキシ
メチル―2(5H)―フラノン
3―メトキシカルボニル―5―n―ブトキシメ
チル―2(5H)―フラノン
なお、本発明の化合物には光学異性体および幾
何学異性体などの立体異性体も存在し得るが、本
発明はこれら立体異性体を包含する。
本発明の化合物は種々の方法により製造される
が、その好ましい一例を挙げれば下記反応式―1
で示される方法がある。
〔式中、R1およびR2は前記と同じ〕
上記反応式―1における化合物(2)からスルフイ
ニル体(3)への酸化反応は通常用いられる有機溶媒
または含水有機溶媒、例えばメタノール、エタノ
ール、アセトン、クロロホルム、ジオキサン、ジ
クロメタンなどを用い、所望により、ピリジン、
希アルカル水溶液の存在下、適当な酸化剤を作用
させることにより行なわれる。用いられる酸化剤
としては、例えば、過ヨウ素酸塩(NaIO4、
KIO4など)、過酸化水素、有機過酸(過酢酸、過
安息香酸、過m―クロル安息香酸など)が挙げら
れる。この酸化反応は、通常−80〜30℃の温度に
て行なわれる。
つぎに化合物(3)から目的化合物(1)への脱スルフ
エン酸反応は、反応に悪影響を及ぼさない溶媒、
例えば、クロロホルム、ジクロルメタン、四塩化
炭素、n―ヘキサン、二硫化炭素、ジエチルエー
テル、ベンゼン、トルエン、キシレン、ピリジン
などの溶媒中、好ましくはベンゼン、トルエン、
キシレン、ピリジンなどの芳香族炭化水素類中で
化合物(3)を加熱することによつて行なわれ、反応
温度は通常、上記溶媒の還流温度とすればよく、
反応は通常10分〜10時間で完結するが、約30分〜
6時間で充分である。
なお、上記の加熱反応において、化合物(3)が油
状物質である場合は、無溶媒にて100〜130℃で30
分〜6時間加熱することによつて目的化合物(1)に
導くことができる。
また該加熱反応において、上記溶媒中に炭酸水
素ナトリウム、炭酸カルシウム、炭酸カリウムな
どの無機塩基物質を化合物(3)に対して等モル〜過
剰モル量、好ましくは等モル〜2倍モル量加える
と、脱スルフエン酸反応の副反応を抑えることが
でき、反応を有利に進行させることができる。
前記反応式―1において、R2が低級アルコキ
シカルボニル基の場合には、化合物(2)を酸化処理
した反応系により直接目的の化合物(1)を得ること
もできる。
この化合物(2)より目的化合物(1)に導くには、酸
化剤として過ギ酸、過酢酸、過安息香酸、過m―
クロロ安息香酸などの有機過酸、好ましくは過m
―クロロ安息香酸を用い、溶媒として、例えば、
ジクロルメタン、クロロホルム、四塩化炭素など
のハロゲン化炭化水素類、ベンゼン、トルエン、
キシレンなどの芳香族炭化水素類を用いて反応を
行なう。好ましい溶媒はハロゲン炭化水素類であ
る。反応温度は一般に−80゜〜40℃、好ましくは
−40℃〜室温付近である。反応時間は通常1〜20
時間、好ましくは2〜10時間である。また、酸化
剤である有機過酸の使用量は、化合物(2)に対して
0.7〜1.5倍モル量、好ましくは0.9〜1.1倍モル量
である。
上記の方法で生成する本発明の化合物は慣用の
分離手段、例えば溶媒抽出、再結晶、カラムクロ
マトグラフイーなどにより反応溶液から容易に単
離精製することができる。
前記反応式―1における出発物質の化合物(2)の
うちR2が水素原子(2a)は下記反応式―2で示
される方法で製造される。
〔式中、R1は前記と同じ〕
すなわち、チオ酢酸誘導体(4)と化合物(5)とを塩
基の存在下、−78℃〜室温で反応させ、一般式(6)
で表わされる化合物に導き、ついでこのものを脱
水閉環して化合物(2a)を得る。
上記一般式(6)の化合物に導く反応は、通常、テ
トラヒドロフラン、エーテル、1,2―ジメトキ
シエタン、N,N―ジメチルホルムアミド、ヘキ
サメチルリン酸トリアミドなどの溶媒中にて行な
われ、使用する塩基としては、n―ブチルリチウ
ムリチウムジイソプロピルアミン、リチウムナフ
タレンなどが挙げられる。その塩基は、化合物(4)
および化合物(5)の理論量に対して、2〜2.5当量
使用するのが好ましい。反応は0℃で化合物(4)の
カルボン酸水素と、活性メチレン水素を塩基で引
きぬき、−78℃〜室温中で活性メチレンにアルキ
ル化を行なうものである。
このようにして得られた化合物(6)は、通常精製
することなく、酸触媒の存在下に脱水閉環反応さ
せることにより化合物(2a)に導かれる。
また前記化合物(2)のうち、R2が低級アルコキ
シカルボニル基である化合物(2b)は、下記反
応式―3で示される方法で製造される。
〔式中、R1は前記と同じ。R3は低級アルキル
基を示す〕
すなわち、化合物(5)とマロン酸ジ低級アルキル
エステル(7)を塩基の存在下、室温から溶媒の沸点
にて、1〜数時間加熱撹拌して化合物(8)に導き、
ついでこれにフエニルチオ基を導入することによ
り容易に製造される。
上記の反応は、通常、適当な溶媒、例えばベン
ゼン、ジオキサン、テトラヒドロフラン、メタノ
ール、エタノール、tert―ブタノール、1,2―
ジメトキシエタン、N,N―ジメチルホルムアミ
ドなどを用いて行なわれる。塩基としては、水素
化ナトリウム、ナトリウムアミド、カリウムtert
―ブトキシド、ナトリウムエトキシド、ナトリウ
ムメトキシドなどが好適に用いられる。使用され
る塩基とマロン酸ジ低級アルキルエステルの量
は、化合物(5)に対して、いずれも理論量の1〜
1.3当量で十分である。
化合物(8)にフエニルチオ基を導入して化合物
(2b)に導く反応は、無水の非プロトン性溶媒
中、無機塩基の存在下、化合物(8)にフエニルチオ
化合物を作用させることにより行なわれる。
上記反応で用いられる非プロトン性溶媒として
は、例えば、n―ヘキサン、ジオキサン、エーテ
ル、クロロホルム、二硫化炭素、ベンゼン、トル
エン、キシレン、テトラヒドロフラン、N,N―
ジメチルホルムアミドなどが挙げられる。無機塩
基としては、水素化ナトリウム、水素化リチウ
ム、ナトリウムアミド、リチウムアミドなどが含
まれ、その用量は、通常、化合物(8)1モル当り、
等モル〜2倍モル量、好ましくは等モル〜1.2倍
モル量の範囲である。フエニルチオ化合物として
は、ベンゼンスルフエニルクロライド
(C6H5SCl)、S―フエニルベンゼンチオスルホネ
ート(C6H5―S―SO2―C6H5)、S―フエニル―
p―トルエンチオスルホネート(C6H5―S―
SO2―C6H4―p―CH3)などが挙げられ、その
用量は、通常、化合物(8)1モル当り、等モル〜2
倍モル量、好ましくは等モル〜1.2倍モル量であ
る。反応は一般に0℃〜溶媒の沸点までの温度範
囲を適宜選択すればよく、反応時間は通常0.5時
間〜20時間、好ましくは1時間〜10時間で進行す
る。
本発明の一般式(1)で示される化合物は、血小板
凝集抑制作用を有し、抗血栓剤として有用であ
る。
また、本発明の化合物の製造中間体として用い
られる一般式(2a),(2b),(3)および(8)で示され
る化合物は、中間体として有用であるほか、それ
らの化合物自体抗アレルギー作用、抗潰瘍作用、
消炎作用、血小板凝集抑制作用および中枢神経抑
制作用を有し、たとえば、抗アレギー剤、抗潰瘍
剤、消炎剤、抗血栓剤、分裂病の治療剤および鎮
静剤などの医薬品として有用である。
つぎに本発明の化合物について参考例および実
施例を挙げて、さらに具体的に示すが、本発明は
これらに限定されるものではない。
参考例 1
α―フエニルチオ―δ―(β―ナフチルオキ
シ)―γ―バレロラクトンの製造
ジイソプロピルアミン11.2gをテトラヒドロフ
ラン60mlに溶かし、その溶液を−20℃まで冷却
し、これにn―ブチルリチウム(15%n―ヘキサ
ン溶液)80mlをゆつくり撹拌下滴下する。混合物
を−20℃で20分撹拌後、フエニルチオ酢酸9.3g
をテトラヒドロフラン20mlに溶かした溶液を−10
〜0℃で加え、撹拌をさらに1時間同様の温度で
続ける。反応混合物を−30℃に再び冷却し、1―
(β―ナフチルオキシ)―2,3―エポキシプロ
パン10gを30分にわたり滴下する。その後、反応
混合物を徐々に室温にもどし、さらに16時間室温
で撹拌する。反応混合物を10%塩酸で酸性とした
のち、エーテル抽出し、有機層を水洗、無水硫酸
マグネシウムで乾燥後、減圧下エーテルを留去す
ると、油状物質19gを得る。このものをベンゼン
150mlに溶かし、濃硫酸2滴を加え、脱水装置を
付して還流器にて6時間還流する。反応混合物を
エーテルで希釈し、有機層を10%炭酸水素ナトリ
ウム水溶液で洗い、その後、水洗、無水硫酸マグ
ネシウムで乾燥後、溶媒を留去すると粗生成物の
結晶17.5gを得る。このものを、ベンゼン―イソ
プロピルエーテルにて再結晶すると、白色結晶の
α―フエニルチオ―δ―(β―ナフチルオキシ)
―γ―バレロラクトン14.5gを得る。融点108〜
109℃
上記参考例1と同様にして下記の表に示す化合
物を得る。Groups represented by [Formula] include prenyl, geranyl, neryl, and farnesyl groups; lower alkoxycarbonyl groups include methoxycarbonyl, ethoxycarbonyl,
Examples include propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, tert-butoxycarbonyl, pentyloxycarbonyl, and hexyloxycarbonyl groups. Representative compounds of the present invention are listed below. 5-phenoxymethyl-2(5H)-furanone 5-(4-chlorophenoxy)methyl-2
(5H)-furanone 5-(4-methylphenoxy)methyl-2
(5H)-furanone 5-(4-methoxyphenoxy)methyl-2
(5H)-furanone 5-(3-trifluoromethylphenoxy)methyl-2(5H)-furanone 5-(2,6-dimethylphenoxy)methyl-
2(5H)-furanone 5-(3-chloro-4-methylphenoxy)methyl-2(5H)-furanone 5-(β-naphthoxy)methyl-2(5H)-furanone 5-(α-naphthoxy)methyl-2 (5H)-furanone 5-(3-methoxy-2-methylphenoxy)
Methyl-2(5H)-furanone 5-(2-bromophenoxy)methyl-2
(5H)-furanone 5-(3-fluorophenoxy)methyl-2
(5H)-furanone 5-(2,3-dimethylphenoxy)methyl-
2(5H)-furanone 5-(4-chloro-5-methylphenoxy)methyl-2(5H)-furanone 5-(α-phenethyloxy)methyl-2
(5H)-furanone 5-(β-phenethyloxy)methyl-2
(5H)-furanone 5-(4-phenylbutoxy)methyl-2
(5H)-furanone 5-diphenylmethoxymethyl-2(5H)-furanone 5-(2,2-diphenylethoxy)methyl-
2(5H)-furanone 5-prenyloxymethyl-2(5H)-furanone 5-geranyloxymethyl-2(5H)-furanone 5-phalnesyloxymethyl-2(5H)-furanone 5-methoxymethyl-2 (5H)-furanone 5-n-butoxymethyl-2(5H)-furanone 5-isopropoxymethyl-2(5H)-furanone 3-ethoxycarbonyl-5-phenoxymethyl-2(5H)-furanone 3-ethoxycarbonyl- 5-(4-chlorophenoxy)methyl-2(5H)-furanone 3-ethoxycarbonyl-5-(2,2-diphenylethoxy)methyl-2(5H)-furanone 3-ethoxycarbonyl-5-diphenylmethoxymethyl -2(5H)-furanone 3-ethoxycarbonyl-5-(β-naphthoxy)methyl-2(5H)-furanone 3-ethoxycarbonyl-5-(α-naphthoxy)methyl-2(5H)-furanone 3-ethoxy Carbonyl-5-geranyloxymethyl-2(5H)-furanone 3-methoxycarbonyl-5-n-butoxymethyl-2(5H)-furanone The compounds of the present invention include optical isomers, geometric isomers, etc. Although stereoisomers may also exist, the present invention encompasses these stereoisomers. The compound of the present invention can be produced by various methods, but a preferred example thereof is the following reaction formula-1.
There is a method shown in [In the formula, R 1 and R 2 are the same as above] The oxidation reaction from compound (2) to sulfinyl compound (3) in the above reaction formula-1 is carried out using commonly used organic solvents or water-containing organic solvents, such as methanol, ethanol, Using acetone, chloroform, dioxane, dichloromethane, etc., if desired, add pyridine,
This is carried out by using a suitable oxidizing agent in the presence of a dilute aqueous alkali solution. Examples of oxidizing agents used include periodate (NaIO 4 ,
KIO 4 , etc.), hydrogen peroxide, and organic peracids (peracetic acid, perbenzoic acid, perm-chlorobenzoic acid, etc.). This oxidation reaction is normally carried out at a temperature of -80 to 30°C. Next, the desulfenation reaction from compound (3) to target compound (1) is carried out using a solvent that does not adversely affect the reaction.
For example, in a solvent such as chloroform, dichloromethane, carbon tetrachloride, n-hexane, carbon disulfide, diethyl ether, benzene, toluene, xylene, pyridine, preferably benzene, toluene,
The reaction is carried out by heating the compound (3) in an aromatic hydrocarbon such as xylene or pyridine, and the reaction temperature is usually the reflux temperature of the above solvent.
The reaction is usually completed in 10 minutes to 10 hours, but it takes about 30 minutes to
6 hours is sufficient. In addition, in the above heating reaction, when compound (3) is an oily substance, it is heated at 100 to 130°C without solvent for 30 minutes.
The target compound (1) can be obtained by heating for minutes to 6 hours. In addition, in the heating reaction, if an inorganic basic substance such as sodium hydrogen carbonate, calcium carbonate, potassium carbonate, etc. is added to the above solvent in an equimolar to excess molar amount, preferably an equimolar to twice molar amount relative to compound (3). , side reactions of the desulfenic acid reaction can be suppressed, and the reaction can proceed advantageously. In Reaction Formula-1, when R 2 is a lower alkoxycarbonyl group, the desired compound (1) can also be directly obtained by a reaction system in which compound (2) is oxidized. In order to lead to the target compound (1) from this compound (2), performic acid, peracetic acid, perbenzoic acid, perm-
An organic peracid such as chlorobenzoic acid, preferably perm
- Using chlorobenzoic acid as a solvent, e.g.
Halogenated hydrocarbons such as dichloromethane, chloroform, carbon tetrachloride, benzene, toluene,
The reaction is carried out using aromatic hydrocarbons such as xylene. Preferred solvents are halogen hydrocarbons. The reaction temperature is generally -80° to 40°C, preferably -40°C to around room temperature. Reaction time is usually 1-20
time, preferably 2 to 10 hours. In addition, the amount of organic peracid used as an oxidizing agent is
It is 0.7 to 1.5 times the molar amount, preferably 0.9 to 1.1 times the molar amount. The compound of the present invention produced by the above method can be easily isolated and purified from the reaction solution by conventional separation means such as solvent extraction, recrystallization, column chromatography, etc. Of the starting material compound (2) in Reaction Formula-1 above, R 2 is a hydrogen atom (2a) is produced by the method shown in Reaction Formula-2 below. [In the formula, R 1 is the same as above] That is, the thioacetic acid derivative (4) and the compound (5) are reacted in the presence of a base at -78°C to room temperature, and the general formula (6) is obtained.
This compound is then subjected to dehydration and ring closure to obtain compound (2a). The reaction leading to the compound of general formula (6) above is usually carried out in a solvent such as tetrahydrofuran, ether, 1,2-dimethoxyethane, N,N-dimethylformamide, hexamethylphosphoric triamide, and the base used. Examples include n-butyllithium lithium diisopropylamine, lithium naphthalene, and the like. The base is compound (4)
It is preferable to use 2 to 2.5 equivalents based on the theoretical amount of compound (5). The reaction involves removing the carboxylic acid hydrogen and active methylene hydrogen of compound (4) at 0°C with a base, and alkylating the active methylene at -78°C to room temperature. Compound (6) obtained in this manner is generally led to compound (2a) by subjecting it to a dehydration ring-closing reaction in the presence of an acid catalyst, without purification. Further, among the compounds (2), the compound (2b) in which R 2 is a lower alkoxycarbonyl group is produced by the method shown in Reaction Formula-3 below. [In the formula, R 1 is the same as above. R 3 represents a lower alkyl group] That is, compound (5) and malonic acid di-lower alkyl ester (7) are heated and stirred in the presence of a base from room temperature to the boiling point of the solvent for 1 to several hours to form compound (8). ),
It is then easily produced by introducing a phenylthio group into this. The above reaction is usually carried out using a suitable solvent such as benzene, dioxane, tetrahydrofuran, methanol, ethanol, tert-butanol, 1,2-
This is carried out using dimethoxyethane, N,N-dimethylformamide, or the like. Bases include sodium hydride, sodium amide, potassium tert.
-butoxide, sodium ethoxide, sodium methoxide, etc. are preferably used. The amounts of the base and malonic acid di-lower alkyl ester used are 1 to 1 of the theoretical amount for compound (5).
1.3 equivalents is sufficient. The reaction of introducing a phenylthio group into compound (8) to lead to compound (2b) is carried out by reacting a phenylthio compound with compound (8) in the presence of an inorganic base in an anhydrous aprotic solvent. Examples of the aprotic solvent used in the above reaction include n-hexane, dioxane, ether, chloroform, carbon disulfide, benzene, toluene, xylene, tetrahydrofuran, N,N-
Examples include dimethylformamide. Examples of the inorganic base include sodium hydride, lithium hydride, sodium amide, lithium amide, etc., and the dosage thereof is usually per mol of compound (8).
The range is from equimolar to 2 times the molar amount, preferably from equimolar to 1.2 times the molar amount. Examples of phenylthio compounds include benzenesulfenyl chloride (C 6 H 5 SCl), S-phenylbenzenethiosulfonate (C 6 H 5 -S-SO 2 -C 6 H 5 ), and S-phenyl-
p-Toluenethiosulfonate (C 6 H 5 -S-
SO 2 --C 6 H 4 --p-CH 3 ), etc., and the dosage is usually from equimole to 2 moles per mole of compound (8).
The amount is twice the molar amount, preferably equimolar to 1.2 times the molar amount. In general, the temperature range of the reaction may be appropriately selected from 0° C. to the boiling point of the solvent, and the reaction time is usually 0.5 hours to 20 hours, preferably 1 hour to 10 hours. The compound represented by the general formula (1) of the present invention has a platelet aggregation inhibiting effect and is useful as an antithrombotic agent. In addition, the compounds represented by general formulas (2a), (2b), (3) and (8) used as intermediates for the production of the compounds of the present invention are not only useful as intermediates, but also have anti-allergic properties. action, anti-ulcer action,
It has anti-inflammatory, platelet aggregation-inhibiting, and central nervous system depressing effects, and is useful as a pharmaceutical agent, such as an anti-allergic agent, an anti-ulcer agent, an anti-inflammatory agent, an anti-thrombotic agent, a therapeutic agent for schizophrenia, and a sedative. Next, reference examples and examples will be given to further specifically illustrate the compounds of the present invention, but the present invention is not limited thereto. Reference Example 1 Production of α-phenylthio-δ-(β-naphthyloxy)-γ-valerolactone 11.2 g of diisopropylamine was dissolved in 60 ml of tetrahydrofuran, the solution was cooled to -20°C, and n-butyllithium (15 % n-hexane solution) was slowly added dropwise while stirring. After stirring the mixture at -20°C for 20 minutes, 9.3 g of phenylthioacetic acid
A solution of -10 dissolved in 20 ml of tetrahydrofuran
Add at ˜0° C. and continue stirring at the same temperature for an additional hour. The reaction mixture was cooled again to -30°C and 1-
10 g of (β-naphthyloxy)-2,3-epoxypropane are added dropwise over 30 minutes. Thereafter, the reaction mixture is gradually warmed to room temperature and stirred for an additional 16 hours at room temperature. The reaction mixture was acidified with 10% hydrochloric acid, extracted with ether, and the organic layer was washed with water, dried over anhydrous magnesium sulfate, and the ether was distilled off under reduced pressure to obtain 19 g of an oily substance. This stuff is benzene
Dissolve in 150 ml, add 2 drops of concentrated sulfuric acid, and reflux for 6 hours in a reflux vessel equipped with a dehydrator. The reaction mixture was diluted with ether, and the organic layer was washed with a 10% aqueous sodium bicarbonate solution, then washed with water, dried over anhydrous magnesium sulfate, and the solvent was distilled off to obtain 17.5 g of crystalline crude product. When this product is recrystallized from benzene-isopropyl ether, white crystals of α-phenylthio-δ-(β-naphthyloxy) are formed.
- Obtain 14.5 g of γ-valerolactone. Melting point 108~
109°C Compounds shown in the table below are obtained in the same manner as in Reference Example 1 above.
【表】【table】
【表】
参考例 2
α―フエニルスルフイニル―δ―(ジフエニル
メトキシ―γ―バレロラクトンの製造
α―フエニルチオ―δ―ジフエニルメトキシ―
γ―バレロラクトン3.2gを塩化メチレン70mlに
溶解した溶液に、m―クロル過安息香酸(70%)
2.2gを氷冷下徐々に加える。その後、氷冷下40
分撹拌したのち、反応混合物を飽和炭酸水素ナト
リウム水溶液約150mlに移し、塩化メチレンで抽
出する。有機層を水洗、無水硫酸マグネシウムで
乾燥後、減圧下40℃以下で溶媒を留去すると粗生
成物3.3gを得る。このものをシリカゲルクロマ
トグラフイにて精製すると油状物質のα―フエニ
ルスルフイニル―δ―(ジフエニルメトキシ―γ
―バレロラクトン3.1gを得る。
IR(cm-1);1060(S―O)NMR(CDCl3、
TMS;ppm)1.90〜3.10(2H)、3.80〜3.88(2H)、
4.12〜4.38(m,1H)、4.40〜4.90(m,1H)、5.26
〜5.43(m,1H)、7.00〜7.60(15H)
上記参考例2と同様にして下記の表に示す化合
物を得る[Table] Reference example 2 Production of α-phenylsulfinyl-δ-(diphenylmethoxy-γ-valerolactone α-phenylthio-δ-diphenylmethoxy-
Add m-chloroperbenzoic acid (70%) to a solution of 3.2 g of γ-valerolactone dissolved in 70 ml of methylene chloride.
Gradually add 2.2g under ice cooling. Then, cool on ice for 40 minutes.
After stirring for several minutes, the reaction mixture is transferred to about 150 ml of saturated aqueous sodium bicarbonate solution and extracted with methylene chloride. After washing the organic layer with water and drying over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure at below 40°C to obtain 3.3 g of a crude product. When this product is purified by silica gel chromatography, an oily substance α-phenylsulfinyl-δ-(diphenylmethoxy-γ
- Obtain 3.1 g of valerolactone. IR (cm -1 ); 1060 (SO) NMR (CDCl 3 ,
TMS; ppm) 1.90-3.10 (2H), 3.80-3.88 (2H),
4.12-4.38 (m, 1H), 4.40-4.90 (m, 1H), 5.26
~5.43 (m, 1H), 7.00 ~ 7.60 (15H) Compounds shown in the table below are obtained in the same manner as in Reference Example 2 above.
【表】【table】
【表】
参考例 3
α―エトキシカルボニル―δ―(α―ナフトキ
シ)―γ―バレロラクトンの製造
ナトリウムエトキサイド溶液(ナトリウム2.8
gと無水エタノール100mlから調製)にマロン酸
ジエチル17.6g(の無水エタノール20ml溶液を50
℃で加える。これに、1―(α―ナフトキシ)―
2,3―エポキシプロパン20gの無水エタノール
20ml溶液を撹拌下35℃で滴下する。その後撹拌を
16時間続ける。反応混合物を15℃に冷却し、酢酸
で酸性とし、過剰のエタノールを減圧下留去した
のち、水を加え、クロロホルムで抽出し、炭酸水
素ナトリウム水溶液で有機層を洗浄し、無水硫酸
マグネシウムで乾燥後、溶媒を留去する。得られ
た結晶を取し、イソプロピルエーテルで洗い、
その粗生成物をエタノール―n―ヘキサンで再結
晶すると白色結晶のα―エトキシカルボニル―δ
―(α―ナフトキシ)―γ―バレロラクトン21g
を得る。融点75〜78℃
上記参考例3と同様にして下記の表に示す化合
物を得る。[Table] Reference example 3 Production of α-ethoxycarbonyl-δ-(α-naphthoxy)-γ-valerolactone Sodium ethoxide solution (sodium 2.8
A solution of 17.6 g of diethyl malonate (prepared from 20 ml of absolute ethanol) and 50 ml of absolute ethanol
Add at °C. To this, 1-(α-naphthoxy)-
2,3-epoxypropane 20g absolute ethanol
Add 20 ml of the solution dropwise at 35°C with stirring. Then stir
Continue for 16 hours. The reaction mixture was cooled to 15°C, acidified with acetic acid, excess ethanol was distilled off under reduced pressure, water was added, extracted with chloroform, the organic layer was washed with an aqueous sodium bicarbonate solution, and dried over anhydrous magnesium sulfate. Afterwards, the solvent is distilled off. The obtained crystals were collected and washed with isopropyl ether.
When the crude product is recrystallized from ethanol-n-hexane, white crystals of α-ethoxycarbonyl-δ
-(α-naphthoxy)-γ-valerolactone 21g
get. Melting point: 75-78°C Compounds shown in the table below are obtained in the same manner as in Reference Example 3 above.
【表】【table】
【表】
参考例 4
α―エトキシカルボニル―α―フエニルチオ―
δ(4―クロルフエノキシ)―γ―バレロラク
トンの製造
α―エトキシカルボニル―δ―(4―クロルフ
エノキシ)―γ―バレロラクトン9gのベンゼン
20ml溶液を、ベンゼン60mlに水素化ナトリウム
1.6gを撹拌した懸濁液に30分を要して室温で滴
下する。その後ベンゼンスルフエニルクロライド
4.5gのベンゼン5ml溶液を反応混合物に滴下し、
3時間室温で反応混合物を撹拌する。反応混合物
を常法により抽出、乾燥、溶媒留去後、シリカゲ
ルクロマトグラフイ(エーテル―n―ヘキサン)
にて精製すると、油状物質のα―エトキシカルボ
ニル―α―フエニルチオ―δ―(4―クロルフエ
ノキシ)―γ―バレロラクトン6.5gを得る。
NMR(CHCl3、TMS;ppm)1.26(t,3H)、
2.32〜3.14(m,2H)、3.84〜4.10(m,2H)、4.24
〜4.24(q,2H)、4.60(m,1H)6.63〜7.69(9H)
実施例 1
α―フエニルスルフイニル―δ―フエノキシ―
γ―バレロラクトン6.4gをトルエン100mlに溶解
し、1時間還流する。その後トルエンを減圧下留
去し、シリカゲルクロマトグラフイ(エーテル―
n―ヘキサン)にて油状反応混合物を精製する
と、白色結晶の5―フエノキシメチル―2(5H)
―フラノン3.3gを得る。融点82〜83℃(n―ヘ
キサン:ベンゼンで再結晶)
実施例 2
α―エトキシカルボニル―α―フエニルチオ―
δ―(4―クロルフエノキシ)―γ―バレロラク
トン6.5gを塩化メチレン150mlに溶解し、氷冷
下、m―クロル過安息香酸(70%)3.9gを徐々
に加え、さらに2時間氷冷下で撹拌を続ける。そ
の後反応混合物を飽和炭酸水素ナトリウム水溶液
に移し、クロロホルムで抽出し、有機層を水洗、
無水硫酸ナトリウムで室温にて2時間を要して乾
燥(この間に脱スルフエン酸反応が完結する)し
たのち、溶媒を留去し、得られた粗生成物をエー
テル―クロロホルムから再結晶して、白色結晶の
3―エトキシカルボニル―5―(4―クロルフエ
ノキシ)メチル―2(5H)―フラノン3.2gを得
る。融点86〜89℃
上記実施例1および2と同様にして下記の表に
示す化合物を得る。表中、3〜10および13〜17の
化合物は実施例1と同様にし、11および12の化合
物は実施例2と同様にして得る。[Table] Reference example 4 α-ethoxycarbonyl-α-phenylthio-
Production of δ(4-chlorophenoxy)-γ-valerolactone 9 g of α-ethoxycarbonyl-δ-(4-chlorophenoxy)-γ-valerolactone in benzene
Add 20ml solution of sodium hydride to 60ml of benzene.
1.6 g was added dropwise to the stirred suspension over 30 minutes at room temperature. Then benzenesulfenyl chloride
A solution of 4.5 g of benzene in 5 ml was added dropwise to the reaction mixture;
Stir the reaction mixture at room temperature for 3 hours. The reaction mixture was extracted by a conventional method, dried, and the solvent was distilled off, followed by silica gel chromatography (ether-n-hexane).
After purification, 6.5 g of oily α-ethoxycarbonyl-α-phenylthio-δ-(4-chlorophenoxy)-γ-valerolactone was obtained. NMR (CHCl 3 , TMS; ppm) 1.26 (t, 3H),
2.32-3.14 (m, 2H), 3.84-4.10 (m, 2H), 4.24
~4.24 (q, 2H), 4.60 (m, 1H) 6.63 ~ 7.69 (9H) Example 1 α-Phenylsulfinyl-δ-phenoxy-
Dissolve 6.4 g of γ-valerolactone in 100 ml of toluene and reflux for 1 hour. Thereafter, toluene was distilled off under reduced pressure, and silica gel chromatography (ether-
When the oily reaction mixture is purified with n-hexane), white crystals of 5-phenoxymethyl-2 (5H) are obtained.
- Obtain 3.3 g of furanone. Melting point 82-83℃ (n-hexane: recrystallized with benzene) Example 2 α-ethoxycarbonyl-α-phenylthio-
Dissolve 6.5 g of δ-(4-chlorophenoxy)-γ-valerolactone in 150 ml of methylene chloride, gradually add 3.9 g of m-chloroperbenzoic acid (70%) under ice-cooling, and further cool with ice for 2 hours. Continue stirring. Thereafter, the reaction mixture was transferred to a saturated aqueous sodium hydrogen carbonate solution, extracted with chloroform, and the organic layer was washed with water.
After drying over anhydrous sodium sulfate at room temperature for 2 hours (during which time the desulfenic acid reaction is completed), the solvent is distilled off, and the resulting crude product is recrystallized from ether-chloroform. 3.2 g of white crystalline 3-ethoxycarbonyl-5-(4-chlorophenoxy)methyl-2(5H)-furanone is obtained. Melting point: 86-89°C Compounds shown in the table below are obtained in the same manner as in Examples 1 and 2 above. In the table, compounds 3 to 10 and 13 to 17 were obtained in the same manner as in Example 1, and compounds 11 and 12 were obtained in the same manner as in Example 2.
【表】【table】
【表】【table】
1 一般式:
[式中、Rは、ハロゲン置換フエニル基であ
り;
R1およびR2は、各々別個に、C1―C4アルキル
基または2―メトキシエチル基であり;
Yは、―(CH2)n―、―CH2CH(CH3)―ま
たは―CH2C(CH3)2―であり;
Xは、未置換もしくは1またはそれ以上のC1
―C4アルキル基、フエニル基、ベンジル基、
CN、―N(R3)2、(CH2)mCO2H、(CH2)
1 General formula: [wherein, R is a halogen-substituted phenyl group; R 1 and R 2 are each independently a C 1 -C 4 alkyl group or a 2-methoxyethyl group; Y is -(CH 2 ) n --, --CH 2 CH (CH 3 ) -- or --CH 2 C (CH 3 ) 2 --; X is unsubstituted or one or more C 1
-C4 alkyl group, phenyl group, benzyl group,
CN, -N( R3 ) 2 , ( CH2 ) mCO2H , ( CH2 )
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55164174A JPS5788174A (en) | 1980-11-20 | 1980-11-20 | 2(5h)-furanone derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55164174A JPS5788174A (en) | 1980-11-20 | 1980-11-20 | 2(5h)-furanone derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5788174A JPS5788174A (en) | 1982-06-01 |
JPS6348270B2 true JPS6348270B2 (en) | 1988-09-28 |
Family
ID=15788125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP55164174A Granted JPS5788174A (en) | 1980-11-20 | 1980-11-20 | 2(5h)-furanone derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5788174A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5164499A (en) * | 1984-05-03 | 1992-11-17 | E. I. Du Pont De Nemours And Company | Nitroaryl carbonyl compounds, nitrodihydroaryl carbonyl intermediates thereto, and processes |
CA1320728C (en) * | 1987-09-07 | 1993-07-27 | Kazuhiko Sakaguchi | Liquid crystalline compounds and process for production thereof |
-
1980
- 1980-11-20 JP JP55164174A patent/JPS5788174A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5788174A (en) | 1982-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2086542C1 (en) | Sulfur-containing imidazole derivatives, method of their synthesis, new intermediate compounds and pharmaceutical composition | |
JP2004043482A (en) | Carboxylic acid derivative | |
FI89908C (en) | BENZOESYRAMELLANPRODUKTER THREADED PRODUCTS | |
JP2001524539A (en) | Method for producing acylated cyclic 1,3-dicarbonyl compound | |
FR2566404A1 (en) | NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR SALTS, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
JPS5982381A (en) | Manufacture of 8,12-epoxy-13,14,15,16- tetranorlabdane | |
JPH013173A (en) | Method for producing oxophthalazinyl acetic acids having a heterocyclic side chain such as benzothiazole | |
JPS6348270B2 (en) | ||
JP3140818B2 (en) | Method for producing insecticidal, nematicidal and acaricidal 2-halo-3-substituted-5-arylpyrrole compounds | |
EP1218366B8 (en) | Method for producing cox-2 inhibitors | |
US6420573B1 (en) | Processes for preparing 3-arylsulfur hydroxamic acids | |
JP2855337B2 (en) | Substituted difluorobenzo-1,3-dioxole and method for producing the same | |
JPS6014032B2 (en) | 5-phenethyl-2-oxazolidone derivative and its production method | |
GB1594450A (en) | 1,3-oxathiolane sulphoxides and their use in the preparation of 5,6-dihydro-2-methyl-1,4-oxathiin derivatives | |
US5663365A (en) | Process for the preparation of pyrazolones | |
JP3146596B2 (en) | Method for producing 3-hydroxymethyl-1-propargylimidazolidine-2,4-dione | |
JPH07215952A (en) | Catechol derivative | |
JP2009504721A (en) | Chemical process | |
JPH0419236B2 (en) | ||
KR100578425B1 (en) | Cathecol Hydrazine Derivatives, Process for Producing the Same and Pharmaceutical Composition Containing the Same | |
EP0309626B1 (en) | Process for the preparation of dibenzothiepin derivative | |
US4150043A (en) | 0-(2,3-Epoxypropyl)-hydroximic acid esters | |
JPH0576478B2 (en) | ||
JP3259206B2 (en) | Method for producing 2-substituted benzo [b] thiophene | |
KR0157511B1 (en) | Process for the preparation of 2-sulfonylthiazole carboxamide derivatives |